ATHENS, Ga. & SAN JOSE, Calif.--(BUSINESS WIRE)--Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness ...
US-based clinical-stage intranasal vaccine company, Blue Lake Biotechnology’s pediatric nasal vaccine for respiratory syncytial virus (RSV), BLB201, was safe and effective for paediatric ...
Hosted on MSN18d
Researchers discover previously unknown gene that indirectly promotes photosynthesis in blue-green algae"In addition, small protein regulators like NirP1 could in future be deployed in 'green' and 'blue' biotechnology for targeted control of the metabolism." More information: Alexander Kraus et al ...
Research analysts at Leerink Partnrs upped their Q4 2024 earnings estimates for shares of bluebird bio in a research report issued on Wednesday, January 22nd. Leerink Partnrs analyst M. Foroohar now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback